| Bariatric Surgery information Gastroesophageal Reflux Disease After Laparoscopic Roux-en-Y Gastric Bypass |
Effect on Gastroesophageal Reflux (GERD) Symptoms After Roux-en-Y Stomach Bypass |
|
Weight Loss Surgery Information - Bariatric Research Studies |
Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypassThe purpose of this study was to determine the effect of laparoscopic Roux-en-Y gastric bypass (LRYGBP) on symptomatic control of gastroesophageal reflux disease (GERD). Method Morbidly obese patients (n = 435) who underwent laparoscopic Roux-en-Y gastric bypass for morbid obesity were assessed for changes in gastroesophageal reflux disease symptoms, quality of life, and patient satisfaction after surgery. Results A total of 238 patients (55%) had evidence of chronic gastroesophageal reflux disease, and 152 patients (64%) voluntarily participated in the study. The mean body mass index (BMI) was 48 kg/m2. The mean excess weight loss was 68.8% at 12 months. There was a significant decrease in GERD-related symptoms, including heartburn (from 87% to 22%); water brash (from 18% to 7%); wheezing (from 40% to 5%) laryngitis (from 17% to 7%); and aspiration (from 14% to 2%) following laparoscopic Roux-en-Y gastric bypass. Postoperatively, the use of medication decreased significantly both for proton pump inhibitors (from 44% to 9%) and for the H2 blockers (from 60% to 10%). SF-36 physical function scores and the mental component summary scores improved after the operation. Overall patient satisfaction was 97%. Conclusion Laparoscopic Roux-en-Y gastric bypass results in very good control of gastroesophageal reflux disease in morbidly obese patients with follow-up as late as 3 years. Morbidly obese patients who require surgery for gastroesophageal reflux disease may be better served by laparoscopic Roux-en-Y gastric bypass than fundoplication because of the additional benefit of significant weight loss. Source: Bariatric Weight Loss Surgery |